Sironax

Developer of drugs for inflammatory and neurodegenerative diseases

placeChangping District, Beijing, China calendar_todayFounded 2017 language sironax.com

Social engagement

Social engagement: 4K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

16 investors on record; lead investors include Gaorong Capital, Yunfeng Capital.

Investor typeCountShare
Venture capital956%
Private equity319%
Other / undisclosed425%

Recent activity

26 Jun 2026
Partnership
Peking
Coming soon